Kellie Toohey1,2,3, Kate Pumpa4,5, Andrew McKune4,5,6, Julie Cooke4,5, Stuart Semple4,5,7. 1. Discipline of Sport and Exercise Science, Faculty of Health, University of Canberra, University Drive, Bruce, Canberra, ACT, 2617, Australia. kellie.toohey@canberra.edu.au. 2. Research Institute for Sport and Exercise, University of Canberra, Canberra, Australia. kellie.toohey@canberra.edu.au. 3. Health Research Institute, University of Canberra, Canberra, Australia. kellie.toohey@canberra.edu.au. 4. Discipline of Sport and Exercise Science, Faculty of Health, University of Canberra, University Drive, Bruce, Canberra, ACT, 2617, Australia. 5. Research Institute for Sport and Exercise, University of Canberra, Canberra, Australia. 6. Discipline of Biokinetics, Exercise and Leisure Sciences, School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa. 7. Health Research Institute, University of Canberra, Canberra, Australia.
Abstract
PURPOSE: There is an increasing body of evidence underpinning high-intensity exercise as an effective and time-efficient intervention for improving health in cancer survivors. The aim of this study was to, (1) evaluate the efficacy and (2) the safety of high-intensity exercise interventions in improving selected health outcomes in cancer survivors. METHODS: Design Systematic review. Data sources Google Scholar and EBSCO, CINAHL Plus, Computers and Applied Sciences Complete, Health Source-Consumer Edition, Health Source: Nursing/Academic Edition, MEDLINE, Web of Science and SPORTDiscuss from inception up until August 2017. Eligibility criteria Randomized controlled trials of high-intensity exercise interventions in cancer survivors (all cancer types) with health-related outcome measures. The guidelines adopted for this review were the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA). RESULTS: The search returned 447 articles, of which nine articles (n = 531 participants mean, age 58 ± 9.5 years) met the eligibility criteria. Exercise interventions of between 4 and 18 weeks consisting of high-intensity interval bouts of up to 4-min were compared with a continuous moderate intensity (CMIT) intervention or a control group. High-intensity exercise interventions elicited significant improvements in VO2 max, strength, body mass, body fat and hip and waist circumference compared with CMIT and/or control groups. The studies reviewed showed low risk in participating in supervised high-intensity exercise interventions. Mixed mode high-intensity interventions which included both aerobic and resistance exercises were most effective improving the aerobic fitness levels of cancer survivors by 12.45-21.35%, from baseline to post-intervention. CONCLUSION: High-intensity exercise interventions improved physical and physiological health-related outcome measures such as cardiovascular fitness and strength in cancer survivors. Given that high-intensity exercise sessions require a shorter time commitment, it may be a useful modality to improve health outcomes in those who are time poor. The risk of adverse events associated with high-intensity exercise was low.
PURPOSE: There is an increasing body of evidence underpinning high-intensity exercise as an effective and time-efficient intervention for improving health in cancer survivors. The aim of this study was to, (1) evaluate the efficacy and (2) the safety of high-intensity exercise interventions in improving selected health outcomes in cancer survivors. METHODS: Design Systematic review. Data sources Google Scholar and EBSCO, CINAHL Plus, Computers and Applied Sciences Complete, Health Source-Consumer Edition, Health Source: Nursing/Academic Edition, MEDLINE, Web of Science and SPORTDiscuss from inception up until August 2017. Eligibility criteria Randomized controlled trials of high-intensity exercise interventions in cancer survivors (all cancer types) with health-related outcome measures. The guidelines adopted for this review were the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA). RESULTS: The search returned 447 articles, of which nine articles (n = 531 participants mean, age 58 ± 9.5 years) met the eligibility criteria. Exercise interventions of between 4 and 18 weeks consisting of high-intensity interval bouts of up to 4-min were compared with a continuous moderate intensity (CMIT) intervention or a control group. High-intensity exercise interventions elicited significant improvements in VO2 max, strength, body mass, body fat and hip and waist circumference compared with CMIT and/or control groups. The studies reviewed showed low risk in participating in supervised high-intensity exercise interventions. Mixed mode high-intensity interventions which included both aerobic and resistance exercises were most effective improving the aerobic fitness levels of cancer survivors by 12.45-21.35%, from baseline to post-intervention. CONCLUSION: High-intensity exercise interventions improved physical and physiological health-related outcome measures such as cardiovascular fitness and strength in cancer survivors. Given that high-intensity exercise sessions require a shorter time commitment, it may be a useful modality to improve health outcomes in those who are time poor. The risk of adverse events associated with high-intensity exercise was low.
Authors: Sue Y S Kimm; Nancy W Glynn; Robert P McMahon; Carolyn C Voorhees; Ruth H Striegel-Moore; Stephen R Daniels Journal: Med Sci Sports Exerc Date: 2006-03 Impact factor: 5.411
Authors: Mary E Cooley; Manan M Nayak; Janet L Abrahm; Ilana M Braun; Michael S Rabin; Jane Brzozowski; Christopher Lathan; Donna L Berry Journal: Psychooncology Date: 2017-07-03 Impact factor: 3.894
Authors: G B Stene; J L Helbostad; T R Balstad; I I Riphagen; S Kaasa; L M Oldervoll Journal: Crit Rev Oncol Hematol Date: 2013-08-09 Impact factor: 6.312
Authors: Caroline S Kampshoff; Mai J M Chinapaw; Johannes Brug; Jos W R Twisk; Goof Schep; Marten R Nijziel; Willem van Mechelen; Laurien M Buffart Journal: BMC Med Date: 2015-10-29 Impact factor: 8.775
Authors: Hendrik Mugele; Nils Freitag; Jannik Wilhelmi; Yanxiang Yang; Sulin Cheng; Wilhelm Bloch; Moritz Schumann Journal: J Cancer Surviv Date: 2019-02-26 Impact factor: 4.442
Authors: Lawson Eng; Dan Pringle; Jie Su; XiaoWei Shen; Mary Mahler; Chongya Niu; Rebecca Charow; Kyoko Tiessen; Christine Lam; Oleksandr Halytskyy; Hiten Naik; Henrique Hon; Margaret Irwin; Vivien Pat; Christina Gonos; Catherine Chan; Jodie Villeneuve; Luke Harland; Ravi M Shani; M Catherine Brown; Peter Selby; Doris Howell; Wei Xu; Geoffrey Liu; Shabbir M H Alibhai; Jennifer M Jones Journal: Support Care Cancer Date: 2018-05-29 Impact factor: 3.603
Authors: M Pollán; S Casla-Barrio; J Alfaro; C Esteban; M A Segui-Palmer; A Lucia; M Martín Journal: Clin Transl Oncol Date: 2020-02-13 Impact factor: 3.405
Authors: Max Oberste; Nils Schaffrath; Katharina Schmidt; Wilhelm Bloch; Elke Jäger; Karen Steindorf; Philipp Hartig; Niklas Joisten; Philipp Zimmer Journal: BMC Cancer Date: 2018-11-06 Impact factor: 4.430
Authors: Kellie Toohey; Kate Pumpa; Andrew McKune; Julie Cooke; Marijke Welvaert; Joseph Northey; Clare Quinlan; Stuart Semple Journal: BMC Cancer Date: 2020-08-20 Impact factor: 4.430